Olive Leaf Extracts in the Control of Cardiovascular Risk
NCT05297110
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Hypertension
Interventions
DRUG:
atherolive
Sponsor
University of Monastir